Sign In
Buy AZN
$181.02
+4.59 (+2.60%)
At Close: Jun 23, 2026
Axxcess Wealth Management LLC Buys 3,541 Shares of AstraZeneca PLC $AZN
04:58am, Friday, 20'th Feb 2026
Axxcess Wealth Management LLC lifted its stake in shares of AstraZeneca PLC (NASDAQ: AZN) by 17.7% during the third quarter, according to its most recent disclosure with the Securities and Exchange Co
AstraZeneca Target of Unusually Large Options Trading (NASDAQ:AZN)
03:01am, Friday, 20'th Feb 2026
AstraZeneca PLC (NASDAQ: AZN - Get Free Report) was the recipient of unusually large options trading activity on Thursday. Traders bought 167,020 call options on the company. This is an increase of ap
JPMorgan Chase & Co. Increases Stake in AstraZeneca PLC $AZN
04:19am, Thursday, 19'th Feb 2026
JPMorgan Chase and Co. raised its holdings in shares of AstraZeneca PLC (NASDAQ: AZN) by 27.8% during the third quarter, according to its most recent filing with the SEC. The firm owned 4,824,072 shar
Impax International Sustainable Economy Fund Q4 2025 Contributors And Detractors
08:47am, Wednesday, 18'th Feb 2026
Impax International Sustainable Economy Fund portfolio marginally underperformed MSCI EAFE benchmark, driven primarily by stock-specific effects and style tilts. AstraZeneca's stock has an attractive
Inside Biotech: AstraZeneca halts generic diabetes pill launch in patent battle with Pharmacor
11:10am, Tuesday, 17'th Feb 2026
In a significant patent skirmish for the Australian biotech and pharmaceutical sector, AstraZeneca PLC (LSE:AZN, NASDAQ:AZN) has secured a Federal Court...
Crestwood Advisors Group LLC Has $40.30 Million Stock Position in AstraZeneca PLC $AZN
05:05am, Tuesday, 17'th Feb 2026
Crestwood Advisors Group LLC boosted its holdings in shares of AstraZeneca PLC (NASDAQ: AZN) by 10.5% during the third quarter, according to the company in its most recent Form 13F filing with the Sec
AstraZeneca (LON:AZN) Hits New 52-Week High – Here’s Why
02:01am, Tuesday, 17'th Feb 2026
AstraZeneca PLC (LON: AZN - Get Free Report) shares reached a new 52-week high during trading on Tuesday. The company traded as high as £151.98 and last traded at £150.74, with a volume of 2093291 s
Shore Capital downgrades AstraZeneca as R&D spending dampens earnings trajectory
10:51am, Friday, 13'th Feb 2026
Shore Capital downgraded AstraZeneca PLC (LSE:AZN, NASDAQ:AZN) to 'hold' from 'buy', citing a less favourable earnings trajectory as the drugmaker prioritises revenue growth through escalating resear
Shore Capital downgrades AstraZeneca as R&D spending dampens earnings trajectory
10:33am, Friday, 13'th Feb 2026
Shore Capital downgraded AstraZeneca PLC (LSE:AZN, NASDAQ:AZN) to 'hold' from 'buy', citing a less favourable earnings trajectory as the drugmaker...
A Closer Look at Healthcare Sector Earnings: AZN vs. EW vs. ZBH
01:27pm, Thursday, 12'th Feb 2026
More than just a financial check-up, earnings for companies in the healthcare sector offer a key window for investors into a firm's pipeline and development progress. Even well-established, stable fir
AstraZeneca Q4 Earnings Call Highlights
02:49am, Thursday, 12'th Feb 2026
AstraZeneca (NASDAQ: AZN) reported full-year and fourth-quarter 2025 results, highlighting revenue growth, expanding "blockbuster" product breadth, and a busy late-stage pipeline as it issued 2026 gui
Citi maintains 'buy' on AstraZeneca with £170 target, cites sector-best pipeline
10:45am, Wednesday, 11'th Feb 2026
Double-digit earnings outlook and strong trial momentum support top pick status AstraZeneca PLC (LSE:AZN, NASDAQ:AZN) remains a top pick at Citi following full-year results and 2026 guidance that the
Citi maintains 'buy' on AstraZeneca with £170 target, cites sector-best pipeline
10:34am, Wednesday, 11'th Feb 2026
Double-digit earnings outlook and strong trial momentum support top pick status AstraZeneca PLC (LSE:AZN, NASDAQ:AZN) remains a top pick at Citi following...
AstraZeneca awards $3.4 million for programs to improve access to healthcare for patients across the US
09:00am, Wednesday, 11'th Feb 2026
WILMINGTON, Del.--(BUSINESS WIRE)--AstraZeneca has proudly awarded $3.4 million to nonprofit organizations in the US through its Accelerate Change Together (ACT) on Health Equity initiative. This effo
OKYO Pharma appoints Leerink Partners as sales agent for ATM equity offering
06:03am, Wednesday, 11'th Feb 2026
OKYO Pharma Ltd (NASDAQ:OKYO) a clinical-stage biopharmaceutical company focused on therapies for neuropathic corneal pain and inflammatory eye diseases,...
